For a patient on insulin, at what blood glucose level should the insulin dose be withheld?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

When to Hold Insulin Based on Blood Glucose Levels

Hold prandial (mealtime) insulin when blood glucose is <70 mg/dL (3.9 mmol/L), and consider holding or reducing basal insulin when blood glucose is <100 mg/dL (5.6 mmol/L), particularly in hospitalized patients with poor oral intake or fasting status. 1, 2

Critical Thresholds for Insulin Management

Hypoglycemia Definitions and Actions

The evidence establishes clear glucose thresholds that should trigger insulin modification:

  • <70 mg/dL (3.9 mmol/L): This is the clinically significant hypoglycemia threshold where insulin should be withheld 1
  • <100 mg/dL (5.6 mmol/L): Fasting glucose levels below this predict hypoglycemia within the next 24 hours in hospitalized patients 2

Type of Insulin Matters

Prandial (rapid-acting) insulin should be held when:

  • Blood glucose <70 mg/dL before meals
  • Patient is not eating or has poor oral intake
  • Recent hypoglycemic episodes occurred

Basal insulin requires more nuanced decision-making:

  • Consider dose reduction (not complete hold) when glucose approaches 100 mg/dL in fasting patients
  • Complete hold may be appropriate if glucose <70 mg/dL or patient has had recent severe hypoglycemia
  • For patients on high-dose home insulin (≥0.6 U/kg/day), reduce total daily dose by 20% upon hospitalization to prevent hypoglycemia 1

Risk-Based Approach

High-Risk Patients Requiring Lower Thresholds

Hold or reduce insulin more aggressively (at higher glucose levels) in:

  • Older patients (>65 years): Use lower insulin doses (0.1-0.25 U/kg/day for basal-plus regimens) 1
  • Renal failure patients: Impaired insulin clearance increases hypoglycemia risk
  • Poor oral intake: Fasting or NPO patients need basal-plus approach rather than full basal-bolus 1
  • Perioperative patients: Reduced insulin requirements during procedures

Clinical Context

The basal-bolus approach carries 4-6 times higher hypoglycemia risk than sliding scale insulin (blood glucose ≤70 mg/dL: risk ratio 5.75; ≤60 mg/dL: risk ratio 4.21) 1. This substantial risk necessitates conservative thresholds for holding insulin.

Practical Algorithm

  1. Check blood glucose before each insulin dose
  2. If glucose <70 mg/dL: Hold prandial insulin; treat hypoglycemia
  3. If glucose 70-100 mg/dL:
    • Hold or reduce prandial insulin by 50% if patient eating poorly
    • Continue basal insulin but monitor closely
  4. If glucose 100-140 mg/dL: Give insulin as ordered but reassess total daily dose
  5. If patient NPO or fasting: Switch to basal-plus regimen (not full basal-bolus) to minimize hypoglycemia risk 1

Common Pitfalls to Avoid

  • Never use sliding scale insulin alone in type 1 diabetes patients - they require basal insulin even when not eating 1
  • Don't continue aggressive basal-bolus regimens in fasting patients - this leads to life-threatening hypoglycemia
  • Avoid premixed insulin (70/30) in hospitals - unacceptably high hypoglycemia rates 1
  • Don't ignore the 100 mg/dL threshold - this predicts hypoglycemia within 24 hours in hospitalized patients 2

The target glucose range for most hospitalized patients is 140-180 mg/dL (7.8-10.0 mmol/L), with insulin initiated for persistent hyperglycemia ≥180 mg/dL 2. This relatively permissive target reflects the substantial mortality risk associated with tight glycemic control and frequent hypoglycemia in the hospital setting.

References

Related Questions

After administering 10 units of morning basal insulin, the fasting glucose is 70 mg/dL; what adjustment, if any, should be made to the insulin dose?
Can Novolin 70/30 (human insulin 70/30) be prescribed three times daily with meals at a total of 18 units for a patient receiving active chemotherapy who has uncontrolled blood glucose?
What initial dose of Lantus (insulin glargine) should be prescribed for a 60-year-old male with type 2 diabetes and an A1c of 9.9% who is medication‑naïve?
What is the recommended 7‑point blood glucose charting protocol for a patient on insulin therapy?
Can NPH insulin be increased by 2 units every three days in adult patients?
For a patient currently taking oxycodone‑acetaminophen 5‑325 mg tablet every 8 hours for pain, how should the opioid be tapered and what orders should be placed?
What is an appropriate discontinuation (taper) strategy for a patient who has been taking low‑dose clonazepam (e.g., 0.5–1 mg daily) for several years?
What are the possible causes of hematuria in a 43-year-old woman?
In a patient with estimated glomerular filtration rate ≥60 mL/min/1.73 m², normal liver enzymes, normal complete blood count, and taking methotrexate, what is the clinical significance of a urinalysis showing no protein but two red blood cells and a negative urine culture?
A patient on duloxetine 60 mg daily continues to experience depression; what is the appropriate next step in management?
What does a persistent pulmonary artery root Doppler signal on fetal ultrasound indicate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.